Geldanamycim-induced cytotoxicity in human colon-cancer cell lines: Evidence against the involvement of c-Src or DT-diaphorase

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 5, 1998, Pages 417-422

  Brunton, Valerie G ^a   Steele, Gregor ^a   Lewis, Alexander D ^a   Workman, P ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

c Src; Colon cancer; DT diaphorase; Geldanmycin

Indexed keywords

GELDANAMYCIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); ANTINEOPLASTIC ANTIBIOTIC; BENZOQUINONE DERIVATIVE; MACROCYCLIC LACTAM; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; QUINONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; ENZYME REPRESSION; ENZYMOLOGY; METABOLISM;

ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; CELL SURVIVAL; ENZYME REPRESSION; HT29 CELLS; HUMANS; LACTAMS, MACROCYCLIC; NAD(P)H DEHYDROGENASE (QUINONE); PROTEIN-TYROSINE KINASES; QUINONES; TUMOR CELLS, CULTURED;

EID: 0031594356     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050760     Document Type: Article

References (33)

1. Benchekroun MN, Myers CE, Sinha BK (1994) Free radical formation by ansamycin benzoquinone in human breast tumor cells implications for cytotoxicity and resistance. Free Rad Biol Med 17: 191
2. Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK (1994) Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol Pharmacol 46: 677
3. Boring CC, Squires TS, Tong T (1992) Cancer statistics, 1992, CA 42: 19
4. Brunton VG, Ozanne BW, Paraskeva C, Frame MC (1997) A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene 14: 283
5. Cartwright CA, Meisler AI, Eckhart W (1990) Activation of the pp60c-src protein kinase is an early event in colon carcinogenesis. Proc Natl Acad Sci USA 87: 558
6. Chavany C, Mimnaugh E, Miller P, Bitton R, Nguyen P, Trepel J, Whitesell L, Schnur R, Moyer JD, Neckers L (1996) p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J Biol Chem 271: 4974
7. Day RS, Ziolkowski CHJ, Scudiero DA, Meyer SA, Mattern MR (1980) Human tumour cell strains defective in the repair of alkylation damage. Carcinogenesis 1: 21
8. Ernster L (1967) DT-diaphorase. Methods Enzymol 10: 309
9. Fitzsimmons SA, Workman P, Grever M, Paull K, Camelier R, Lewis AD (1996) Reductase expression across the National Cancer Institute tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 88: 259
10. Garcia R, Parikh NU, Saya H, Gallick GE (1991) Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. Oncogene 6: 1983
11. Hartson SD, Barret DJ, Burn P, Matts RL (1996) Hsp-90-mediated folding of the lymphoid-cell kinase p56. Biochemistry 35: 13451
12. McIlrath AJ, Brunton VG, Brown R (1996) Cell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells. Cancer Chemother Pharmacol 37: 423
13. Miller P, Schnur RC, Barbacci E, Moyer JD (1994) Binding of benzoquinoid ansamycins to p100 correlates with their ability to deplete the erbB2 gene-product p185. Biochem Biophys Res Commun 201: 1313
14. Mimnaugh EG, Chavany C, Neckers L (1996) Polyubiquitination and proteosomal degradation of the p185(c-erbB-2) receptor protein tyrosine kinase induced by geldanamycin. J Biol Chem 271: 22796
15. Plumb JA, Workman P (1994) Unusually marked hypoxic sensitisation to indoloquinone and mitomycin C in a human colon-tumor cell line that lacks DT-diaphorase activity. Int J Cancer 56: 134
16. Powis G (1987) Metabolism and reaction of quinoid anticancer agents. Pharmacol Ther 35: 57
17. Riley RJ, Workman P (1992) DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43: 1657
18. Ross D, Beall HD, Siegel D, Traver RD, Gustafson DL (1996) Enzymology of bioreductive drug activation. Br J Cancer 74: S1
19. Schlager JJ, Powis G (1990) Cytosolic NAD(P)H:(quinone-acceptor) oxidoreductase in normal human and tumour tissue: effects of cigarette smoking and alcohol. Int J Cancer 45: 403
20. Siegel D, Gibson NW, Preusch PC, Ross D (1990) Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50: 7483
21. Smith DF, Whitesell L, Nair SC, Chen SY, Prapananich V, Rimerman RA (1995) Progesterone-receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 15: 6804
22. Supko JG, Hickman RL, Grever MR, Malspeis L (1995) Pre-clinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 36: 305
23. Talamonti MS, Roh MS, Curley SA, Gallick GE (1993) Increase in activity and level of pp60-src in progressive stages of human colorectal cancer. J Clin Invest 91: 53
24. Traver RD, Horikoshi T, Danenberg KD, Stadibauer THW, Danenberg PV, Ross D, Gibson NW (1992) NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52: 797
25. Uehara Y, Hori M, Takeuchi T, Umezawa H (1985) Screening of agents which convert 'transformed morphology': identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn J Cancer Res 76: 672
26. Uehara Y, Hori M, Takeuchi T, Umezawa H (1986) Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6: 2198
27. Uehara Y, Murakami Y, Sugimoto Y, Mizuno S (1989) Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src. Cancer Res 49: 780
28. Walton MI, Smith PJ, Workman P (1991) The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun 3: 199
29. Walton MI, Bibby MC, Double JA, Plumb JA, Workman P (1992) DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas. Eur J Cancer 28A: 1597
30. Whitesell L, Cook P (1996) Stable and specific binding of the heat-shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol 10: 705
31. Whitesell L, Shifrin SD, Schwab G, Neckers LM (1992) Benzoquinonoid ansamyceins possess selective tumoricidal activity unrelated to src kinase inhibition. Cancer Res 52: 1721
32. Whitesell L, Mimnaugh EG, DeCosta B, Myers CE, Neckers LM (1994) Inhibition of the heat-shock protein hsp90-pp60 (v-Src) heteroprotein complex-formation by benzoquinone ansamyeins - essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91: 8324
33. Workman P (1994) Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol Res 6: 461